domingo, 21 de abril de 2024

FDA OKs Subcutaneous Vedolizumab for Crohn's Maintenance Therapy Megan Brooks April 19, 2024

https://www.medscape.com/viewarticle/fda-oks-subcutaneous-vedolizumab-crohns-maintenance-therapy-2024a10007mr?src=

No hay comentarios:

Publicar un comentario